Laddar...
ERCC1 protein as a guide for individualized therapy of late-stage advanced non-small cell lung cancer
Excision repair cross-complementation group 1 (ERCC1) protein has been associated with cisplatin resistance. The objective of this study was to investigate the correlation between ERCC1 protein levels and the therapeutic effect of individualized therapy in advanced non-small cell lung cancer (NSCLC)...
Sparad:
| Huvudupphovsmän: | , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
D.A. Spandidos
2011
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3440707/ https://ncbi.nlm.nih.gov/pubmed/22977580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2011.276 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|